Elevated BCR signaling activity in CLL cells promotes survival and proliferation, and prognostic markers such as IgVH mutational status, ZAP-70, and CCL3 are associated with enhanced BCR signaling, suggesting a relationship with worse prognosis [74,75]. Here, CCL3 is linked to B-cell chronic lymphocytic leukemia.